TD Cowen 46th Annual Health Care Conference

3/3/2026 | 3:10pm ET

Webcast Link

Leerink Partners Global Healthcare Conference

3/10/2026 | 1:40pm ET

Webcast Link

Barclays 28th Annual Global Healthcare Conference

3/11/2026 | 1-on-1 meetings

Events & Presentations

  • Barclays 28th Annual Global Healthcare Conference

    03/11/2026 | 9:00pm PDT / 12:00am EDT

  • Leerink Partners Global Healthcare Conference

    03/10/2026 | 10:40am PDT / 1:40pm EDT

    Watch the webcast

  • TD Cowen 46th Annual Health Care Conference

    03/03/2026 | 12:10pm PST / 3:10pm EST

    Watch the webcast
View all events

Financial Reports and Filings

Date Filing Title Downloads
04/15/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
04/15/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
04/14/2026 ARS An annual report to security holders RTF XLS PDF HTML XBRL
04/14/2026 DEFA14A Additional proxy soliciting materials - definitive RTF XLS PDF HTML XBRL
04/14/2026 DEF 14A Official notification to shareholders of matters to be brought to a vote ("Proxy") RTF XLS PDF HTML XBRL
04/07/2026 SCHEDULE 13G/A SCHEDULE 13G/A - Description RTF XLS PDF HTML XBRL
03/27/2026 SCHEDULE 13G/A SCHEDULE 13G/A - Description RTF XLS PDF HTML XBRL
03/23/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
03/23/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
03/23/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
View all filings

Latest News

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026 Thumbnail

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026

Apr 16, 2026 | Products

Read more
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan Thumbnail

Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan

Apr 14, 2026 | Products

Read more
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting Thumbnail

Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting

Apr 09, 2026 | Products

Read more
View all news releases

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Read our QICR report

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Read our QICR report